Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04276051 · ClinicalTrials.gov registry record · NA

Cryovagotomy Diabetes Trial

A NA study of Obesity and Diabetes Mellitus, sponsored by Emory University.

Completed
Registry status
NA
Development phase
5
Enrollment target
5
Study locations

NCT04276051 is a NA study of Obesity and Diabetes Mellitus that has completed, run by Emory University. The registered enrollment target is 5 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (99% lower). The trial reports 5 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04276051, a NA study of Obesity and Diabetes Mellitus, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
5 participants
Enrollment target
5
Study locations

Study Summary

The pilot study will assess the feasibility and efficacy of cryoablation procedure to freeze the vagus nerve in obese patients with type 2 diabetes. Aim 1 will focus on changes in glycemic control. Aim 2 will evaluate differences in body weight and anthropometric measurements. This study will provide much needed data for a novel therapeutic intervention to manage obese patients with type 2 diabetes.

Interventions

  • BEHAVIORAL Lifestyle Intervention
  • DEVICE Cryoablation of the Vagus Nerve

Study Locations (5)

Georgia

  • Emory University Hospital Midtown - Atlanta
  • Emory University Hospital - Atlanta
  • Grady Health System - Atlanta
  • The Emory Clinic - Atlanta
  • Emory Johns Creek Hospital - Johns Creek

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2020-10-23
Est. Completion 2022-02-08
Phase NA

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT04276051

The ClinicalTrials.gov registry entry for NCT04276051 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (99% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Lifestyle Intervention is the first listed.

NCT04276051 reports 5 study locations spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT04276051 about?

NCT04276051 is a clinical study titled "Cryovagotomy Diabetes Trial". The pilot study will assess the feasibility and efficacy of cryoablation procedure to freeze the vagus nerve in obese patients with type 2 diabetes. Aim 1 will focus on changes in glycemic control. Aim 2 will evaluate differences in body weight and anthropometric measurements. This study will provid...

What is the current status of trial NCT04276051?

This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2020-10-23. Estimated completion is 2022-02-08.

What conditions does trial NCT04276051 study?

This clinical trial studies the following conditions: Obesity, Diabetes Mellitus, Diabetes Type 2.

What interventions are being tested in trial NCT04276051?

The interventions under investigation include: Lifestyle Intervention (BEHAVIORAL), Cryoablation of the Vagus Nerve (DEVICE).

Who is sponsoring clinical trial NCT04276051?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04276051 being conducted?

This trial has 5 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.